HDAC6 and glioblastoma: Additionally, methionine sulfoximine (MSO) treatment hindered the rescue of cell growth upon supplementation of glutamate and ammonia, demonstrating that HDAC6 and USP9X maintain GBM cell growth by modulating GS activity.